| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | dexmedetomidine (Dexmedetomidine EVER Pharma®) |
| Formulation | 100 micrograms/ml concentrate for solution for infusion |
| Reference number | 3952 |
| Indication | Sedation of adult Intensive Care Unit patients requiring sedation level not deeper than arousal in response to verbal stimulation (corresponding to Richmond Agitation-Sedation Scale [RASS] 0 to -3); sedation of non-intubated adult patients prior to and/or during diagnostic or surgical procedures requiring sedation, i.e. procedural/awake sedation |
| Company | EVER Valinject GmbH |
| BNF chapter | Anaesthesia |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 08/11/2018 |